Project Grant HT94252510769
Award Date 11/1/25
Completion Date 10/31/28
Dollars Obligated $1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
- The Defense Health Agency awarded a $799,998 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation in Cleveland, Ohio. The purpose of this 3-year grant is to conduct research on "Strategies Enhancing Spinal Plasticity to Promote Recovery from Spinal Cord Injury." The grant aims to develop innovative treatments and medical solutions to transform healthcare for military service members, veterans, and the broader public....
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $999,999 Project Grant to The Cleveland Clinic Foundation to conduct research on "Inhibiting Demyelination Rescues Synapse Loss in Multiple Sclerosis." The grant period runs from June 1, 2024 to May 31, 2027. The Cleveland Clinic Foundation, a non-profit academic medical center, will use the funding to carry out innovative biomedical research aimed at developing new treatments...
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $650,138 Project Grant to The Cleveland Clinic Foundation on September 1, 2024. The grant will fund a 2-year study focused on developing biomarkers to assess patient response to neurorestorative therapies for cervical spinal cord injuries. The Cleveland Clinic Foundation, a non-profit academic medical center, will leverage its expertise in neuroscience research to advance this...
- The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
- The Defense Health Agency awarded a $1,139,124 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development program (CFDA 12.420) on May 1, 2025. The grant funds research focused on "NOVEL NUCLEAR LOCALIZATION OF THE COMPLEMENT REGULATOR CD55 IDENTIFIES A NEW HOOK FOR DISRUPTING OVARIAN CANCER PROGRESSION." This 4-year research project aims to explore innovative approaches to treating ovarian cancer. As a prominent non-profit academic medical...
- The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $2,602,024 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2024, will fund research on the "Role of Stress in the Degradation of Intestinal IgA and Intestinal Health" over a 4-year period ending on September 29, 2028. As a prominent academic medical center, The Cleveland Clinic Foundation...
- The Defense Health Agency awarded a $780,357 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports research into the novel nuclear localization of the complement regulator CD55 and its potential to disrupt ovarian cancer progression. The award period runs from May 1, 2025 to April 30, 2029. As a prominent non-profit academic medical center, The Cleveland Clinic Foundation leverages its expertise in areas...
- The Department of Defense's Defense Health Agency awarded The Cleveland Clinic Foundation a $383,740 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the research and development of a "Novel Graft-Localized Drug Delivery Platform for Attenuating Innate Inflammation and Optimizing Immunosuppression in Vascularized Composite Allotransplantation." This project aims to develop innovative medical...
- The Defense Health Agency awarded a $559,992 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development program (CFDA 12.420) to develop a superior CAR T-cell therapy for leukemia. The grant funds bench-to-bedside research aimed at transforming healthcare for military service members, veterans, and the public. The project will run from September 30, 2025 to September 29, 2028 and leverage the Cleveland Clinic's expertise in oncology, immunology, and...
- The Defense Health Agency has awarded a $1,917,278 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development program (CFDA 12.420) to support the development of "Neupron" for the treatment of acute spinal cord injury. The award, with a performance period from July 1, 2025 to June 30, 2028, will fund research focused on identifying surrogate biomarkers to evaluate the efficacy of this novel treatment. As a prominent non-profit academic...